Group 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy
1 clinical trials · Condition
◉ Watch Group 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy
| Record | Firm | Date |
|---|---|---|
| Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI (NCT04391322) | The Hospital for Sick Children | 2020-10-20 |
Track Group 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy automatically
Every clearance here is in the API, with alerts when new ones post.